Cardiovascular benefits of SGLT2 inhibition in diabetes and chronic kidney diseases
Acta Physiologica,Volume 222, Issue 4, April 2018.
Source: Acta Physiologica - Category: Physiology Source Type: research
More News: Cardiology | Cardiovascular | Chronic Kidney Disease | Diabetes | Endocrinology | Heart | Physiology | SGLT2 Inhibitors | Urology & Nephrology